30 Sep Cell Processing and Isolation Platform
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text css="" el_class="portfolio-content"] cTRL Therapeutics Advancing cell therapy through automation Impact Circulating Tumor-Reactive Lymphocytes (cTRLs) represent a powerful new frontier in cancer immunotherapy. By enabling gentle, efficient isolation of these rare cells, the collaboration between cTRL Therapeutics and Key Tech is helping...











